UK Stocks to Watch on June 24: First Property, Latham, Persimmon, Puretech Health, GlaxoSmithKline

Follow us on Google News:
 UK Stocks to Watch on June 24: First Property, Latham, Persimmon, Puretech Health, GlaxoSmithKline
Image source: ramcreations,

The following FTSE listed stocks First Property (LON: FPO), Latham (LON: LTHM), Persimmon (LON: PSN), Puretech Health (LON: PRTC), GlaxoSmithKline (LON: GSK) are set to make headlines today.

  1. First Property Group plc (LON: FPO)

FTSE AIM All-Share index constituent First Property Group, a property fund manager and investor, announced its preliminary FY 2021 results today, for the period ending twelve months to 31 March 2021.

FPO reported a loss before tax of £5.09 million in FY 2021 compared to a profit before tax of £5.52 million in FY 2020. However, its cash reserves increased to £16.24 million from £7.34 million in the year before.

FPO’s shares closed at GBX 35.15, down by 0.28 per cent on 23 June.

  1. Latham (James) Plc (LON: LTHM)

Latham (James) Plc, one of the UK’s largest independent trade distributors of timber, decorative surfaces and panels and an FTSE AIM All-Share index constituent, reported a revenue increase of 1.3 per cent to £250.2 million for FY 2021 this morning, as compared to £247.1 million in FY 2020. It’s like-for-like volumes also increased by 6.6 per cent in FY 2021, with a majority of the growth coming from its delivered business.

The company’s profit before tax increased by £2.9 million to £18.6m in FY 2021, from £15.7 million in the year before.

LTHM’s shares had closed at GBX 1,080.00, up by 4.85 per cent on 23 June.

  1. Persimmon Plc (LON: PSN)

FTSE 100 listed homebuilding company Persimmon has agreed to adhere to several voluntary undertakings following an investigation from the UK competition regulatory body, the Competition and Markets Authority (CMA) related to overcharging and high ground rent terms.

PSN agreed to extend its Right to buy scheme and cap its freehold buying price at £2,000, repayment to freehold homeowners who paid more than the price of £2,000 and an extension of its home buyer reservation period from 35 to 42 days.

PSN’s shares closed at GBX 2,975.00, down by 1.72 per cent on 23 June.

  1. Puretech Health Plc (LON: PRTC)

FTSE 250 index constituent Puretech Health, a clinical stage bio-therapeutics company, announced late Wednesday that tis founded entity Karuna reported results from its completed Phase 1b trial.

The trial was aimed at evaluating the safety and tolerability of KarXT (xanomeline-trospium) in healthy elderly volunteers. The results were consistent with prior trials.

PRTC has an 8.2 per cent ownership of Karuna and a right to royalty payments as a percentage of Karuna’s net sales.

PRTC’s shares closed at GBX 346.00, down by 0.29 per cent on 23 June.

  1. GlaxoSmithKline Plc (LON: GSK)

FTSE 100 index listed company GlaxoSmithKline, a UK-based multinational pharmaceutical major, announced a new strategy and growth outlook on Wednesday, as GSK confirmed plans to demerge its consumer healthcare business in mid 2022.

The new GSK targets a sale growth of more than 5 per cent and adjusted operating growth over 10 per cent between 2021 and 2026 on a CAGR basis. Additionally, the new GSK company targets sales of up to £33 billion by 2031.

It also announced its 2022 aggregate divided for GSK and the new consumer healthcare business to be at about 55 pence per share.

GSK’s shares closed at GBX 1,409.20, up by 1.03 per cent on 23 June.


The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Featured Articles